Orexins/hypocretins and orexin receptors in apoptosis: A mini-review

Acta Physiologica

Volumn 198, Issue 3, 2010, Pages 393-402

  Laburthe, M ^a   Voisin, T ^a   El Firar, A ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

G protein coupled receptor; Heptahelical receptor; Phosphotyrosine phosphatase; SH2 domain containing tyrosine phosphatase 2; Tyrosine based motif

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 1 (6,8 DIFLUORO 2 METHYL 4 QUINOLINYL) 3 (4 DIMETHYLAMINOPHENYL)UREA; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BRADYKININ RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GALANIN RECEPTOR; INTERLEUKIN 8 RECEPTOR; JNJ 10397049; MEMBRANE PROTEIN; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROTENSIN RECEPTOR; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; PHOSPHATIDYLSERINE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RECOMBINANT PROTEIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; TACHYKININ RECEPTOR; TYROSINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING AFFINITY; CANCER GROWTH; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; CONFERENCE PAPER; DEGENERATIVE DISEASE; DNA FRAGMENTATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC TRANSDUCTION; GLUCOSE TRANSPORT; HORMONE RECEPTOR INTERACTION; HUMAN; INTESTINE CELL; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NEUROPATHOLOGY; NONHUMAN; PANCREAS TUMOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 75749152568     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02035.x     Document Type: Conference Paper

References (71)

1. + influx that eventually result in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation. Leukemia 21, 788 796.
2. Ammoun, S., Lindholm, D., Wootz, H., Akerman, K.E. Kukkonen, J.P. 2006. G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress- activated protein kinase. J Biol Chem 281, 834 842.
3. Asahi, S., Egashira, S., Matsuda, M., Iwaasa, H., Kanatani, A., Ohkubo, M., Ihara, M. Morishima, H. 2003. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B. Bioorg Med Chem Lett 13, 111 113.
4. Baumann, C.R., Clark, E.L., Pedersen, N.P., Hecht, J.L. Scammell, T.E. 2008. Do enteric neurons make hypocretin? Regul Pept 147, 1 3.
5. Bengtsson, M.W., Makela, K., Sjoblom, M., Uotila, S., Akerman, K.E., Herzig, K.H. Flemstrom, G. 2007. Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A. Am J Physiol Gastrointest Liver Physiol 293, G501 G509.
6. Bengtsson, M.W., Makela, K., Herzig, K.H. Flemstrom, G. 2009. Short food deprivation inhibits orexin receptor 1 expression and orexin-A induced intracellular calcium signaling in acutely isolated duodenal enterocytes. Am J Physiol Gastrointest Liver Physiol 296, G651 G658.
7. Boss, C., Brisbare-Roch, C. Jenck, F. 2009. Biomedical application of orexin/hypocretin receptor ligands in neuroscience. J Med Chem 52, 891 903.
8. Boutrel, B. De Lecea, L. 2008. Addiction and arousal: the hypocretin connection. Physiol Behav 93, 947 951.
9. Bredesen, D.E., Rao, R.V. Mehlen, P. 2006. Cell death in the nervous system. Nature 443, 796 802.
10. Bruhns, P., Marchetti, P., Fridman, W.H., Vivier, E. Daeron, M. 1999. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol 162, 3168 3175.
11. Carethers, J.M., Smith, E.J., Behling, C.A., Nguyen, L., Tajima, A., Doctolero, R.T., Cabrera, B.L., Goel, A., Arnold, C.A., Miyai, K. Boland, C.R. 2004. Use of 5-fluorouracil and survival in patients with microsatellite- unstable colorectal cancer. Gastroenterology 126, 394 401.
12. Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N. Sexton, P.M. 2003. Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278, 3293 3297.
13. Conforti, L., Adalbert, R. Coleman, M.P. 2007. Neuronal death: where does the end begin? Trends Neurosci 30, 159 166.
14. Couvineau, A., Darmoul, D., Blais, A., Rouyer-Fessard, C., Daviaud, D., Voisin, T., Paris, H., Rouot, B. Laburthe, M. 1992. Gs and Gi protein subunits during cell differentiation in intestinal crypt-villus axis: regulation at the mRNA level. Am J Physiol 262, C1478 C1484.
15. Daeron, M., Jaeger, S., Du, P.L. Vivier, E. 2008. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 224, 11 43.
16. Darmoul, D., Marie, J.C., Devaud, H., Gratio, V. Laburthe, M. 2001. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 85, 772 779.
17. Darmoul, D., Gratio, V., Devaud, H. Laburthe, M. 2004a. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem 279, 20927 20934. (Pubitemid 38656491)
18. Darmoul, D., Gratio, V., Devaud, H., Peiretti, F. Laburthe, M. 2004b. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2, 514 522. (Pubitemid 39281733)
19. De Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., 2nd., Frankel, W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M. Sutcliffe, J.G. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95, 322 327.
20. De Zio, D., Giunta, L., Corvaro, M., Ferraro, E. Cecconi, F. 2005. Expanding roles of programmed cell death in mammalian neurodevelopment. Semin Cell Dev Biol 16, 281 294.
21. Deshmukh, M., Du, C., Wang, X. Johnson, E.M. 2002. Exogenous Smac induces competence and permit caspase activation in sympathetic neurons. J Neurosci 22, 8018 8027.
22. Ducroc, R., Voisin, T., El Firar, A. Laburthe, M. 2007. Orexins control intestinal glucose transport by distinct neuronal, endocrine, and direct epithelial pathways. Diabetes 56, 2494 2500.
23. El Firar, A., Voisin, T., Rouyer-Fessard, C., Ostuni, M.C. Laburthe, M. 2009. Discovery of a functional immunoreceptor tyrosine-based switch motif (ITSM) in a seven transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis. FASEB J 6 Aug [Epub ahead of print].
24. Flemström, G., Sjöblom, M., Jedstedt, G. Akerman, K.E. 2003. Short fasting dramatically decreases rat duodenal secretory responsiveness to orexin A but not to VIP or melatonin. Am J Physiol Gastrointest Liver Physiol 285, G1091 G1096.
25. Frucht, H., Jensen, R.T., Dexter, D., Yang, W.L. Xiao, Y. 1999. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res 5, 2532 2539.
26. Funato, H., Tsai, A.L., Willie, J.T., Kisanuki, Y., Williams, S.C., Sakurai, T. Yanagisawa, M. 2009. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 9, 64 76.
27. Gentili, C., Boland, R. Russo de Boland, A. 2006. Implication of Gbetagamma proteins and c-SRC tyrosine kinase in parathyroid hormone-induced signal transduction in rat enterocytes. J Endocrinol 188, 69 78.
28. Gether, U., Asmar, F., Meinild, A.K. Rasmussen, S.G. 2002. Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol 91, 304 312.
29. Harris, G.C. Aston-Jones, G. 2006. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 29, 571 577.
30. Heinonen, M.V., Purhonen, A.K., Makela, K.A. Herzig, K.H. 2008. Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 192, 471 485.
31. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M.J. Shoelson, S.E. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441 450.
32. Holmqvist, T., Johansson, L., Ostman, M., Ammoun, S., Akerman, K.E. Kukkonen, J.P. 2005. OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J Biol Chem 280, 6570 6579.
33. 2+ influx. Br J Pharmacol 150, 97 104. (Pubitemid 46094674)
34. Johnson, C.E., Huang, Y.Y., Parrish, A.B., Smith, M.I., Vaughn, A.E., Zhang, Q., Wright, K.M., Van Dyke, T., Wechsler-Reya, R.J., Kornbluth, S. Deshmukh, M. 2007. Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci USA 104, 20820 20825.
35. Johren, O., Neidert, S.J., Kummer, M., Dendorfer, A. Dominiak, P. 2001. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142, 3324 3331.
36. Jones, B.A. Gores, G.J. 1997. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol 273, G1174 G1188.
37. Karteris, E., Randeva, H.S., Grammatopoulos, D.K., Jaffe, R.B. Hillhouse, E.W. 2001. Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. Endocrinology 86, 4512 4519.
38. Karteris, E., Chen, J. Randeva, H.S. 2004. Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system. J Clin Endocrinol Metab 89, 1957 1962.
39. Kirchgessner, A.L. Liu, M. 1999. Orexin synthesis and response in the gut. Neuron 24, 941 951.
40. Lang, M., Soll, R.M., Durrenberger, F., Dautzenberg, F.M. Beck-Sickinger, A.G. 2004. Structure-activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands. J Med Chem 47, 1153 1160.
41. Li, F., Srinivasan, A., Wang, Y., Armstrong, R.C., Tomaselli, K.J. Fritz, L.C. 1997. Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release. J Biol Chem 272, 30299 30305.
42. Liu, X., Kim, C.N., Yang, J., Jemmerson, R. Wang, X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147 157.
43. 2+ influx pathway necessary for coupling to phopholipase C. J Biol Chem 275, 30806 30812.
44. 2+ signalling by the orexin receptor type 1. Biochem Pharmacol 71, 827 836.
45. Maoret, J.J., Anini, Y., Rouyer-Fessard, C., Gully, D. Laburthe, M. 1999. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer 80, 448 454.
46. McAtee, L.C., Sutton, S.W., Rudolph, D.A., Li, X., Aluisio, L.E., Phuong, V.K., Dvorak, C.A., Lovenberg, T.W., Carruthers, N.I. Jones, T.K. 2004. Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists. Bioorg Med Chem Lett 14, 4225 4229.
47. McLatchie, L.M., Fraser, N.J., Main, M.J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M.G. Foord, S.M. 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333 339.
48. 2+ entry via diacylglycerol-activated channels in differentiated neuroblastoma cells. J Neurosci 26, 10658 10666.
49. Nurmio, M., Tena-Sempere, M. Toppari, J. 2009. Orexins and the regulation of the hypothalamic-pituitary-testicular axis. Acta Physiol (Oxf) 20 May [Epub ahead of print].
50. Ostrakhovitch, E.A. Li, S.S. 2006. The role of SLAM family receptors in immune cell signaling. Biochem Cell Biol 84, 832 843.
51. Potts, P.R., Linhoff, M.W., Ryan Potts, P. Deskmukh, M. 2003. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol 163, 789 799.
52. Ramanjaneya, M., Conner, A.C., Chen, J., Stanfield, P.R. Randeva, H.S. 2008. Orexins stimulate steroidogenic acute regulatory protein expression through multiple signaling pathways in human adrenal H295 cells. Endocrinology 149, 4106 4115.
53. Ravetch, J.V. Lanier, L.L. 2000. Immune inhibitory receptors. Science 290, 84 89.
54. Ribe, E.M., Serrano-Saiz, E., Akpan, N. Troy, C.M. 2008. Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 415, 165 182.
55. Rizzuto, R., Pinton, P., Ferrari, D., Chami, M., Szabadkai, G., Magalhaes, P.J., Di Virgilio, F. Pozzan, T. 2003. Calcium and apoptosis: facts and hypotheses. Oncogene 22, 8619 8627.
56. Rouet-Benzineb, P., Rouyer-Fessard, C., Jarry, A., Avondo, V., Pouzet, C., Yanagisawa, M., Laboisse, C., Laburthe, M. Voisin, T. 2004. Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis. J Biol Chem 279, 45875 45886.
57. Rozengurt, E., Guha, S. Sinnett-Smith, J. 2002. Gastrointestinal peptide signalling in health and disease. Eur J Surg 587, 23 38.
58. Sakurai, T. 2007. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8, 171 181.
59. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S. et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573 585.
60. Salomon, R., Couvineau, A., Rouyer-Fessard, C., Voisin, T., Lavallée, D., Blais, A., Darmoul, D. Laburthe, M. 1993. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Am J Physiol 264, E294 E300.
61. Shlapatska, L.M., Mikhalap, S.V., Berdova, A.G., Zelensky, O.M., Yun, T.J., Nichols, K.E., Clark, E.A. Sidorenko, S.P. 2001. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 166, 5480 5487.
62. Silveyra, P., Lux-Lantos, V. Libertun, C. 2007. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation. Am J Physiol Endocrinol Metab 293, E977 E985.
63. Smart, D., Sabido-David, C., Brough, S.J., Jewitt, F., Johns, A., Porter, R.A. Jerman, J.C. 2001. SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 132, 1179 1182.
64. Tang, J., Chen, J., Ramanjaneya, M., Punn, A., Conner, A.C. Randeva, H.S. 2008. The signalling profile of recombinant human orexin-2 receptor. Cell Signal 20, 1651 1661.
65. Voisin, T., Rouyer-Fessard, C. Laburthe, M. 1990. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis. Am J Physiol 258, G753 G759.
66. Voisin, T., Rouet-Benzineb, P., Reuter, N. Laburthe, M. 2003. Orexins and their receptors: structural aspects and role in peripheral tissues. Cell Mol Life Sci 60, 72 87.
67. Voisin, T., El Firar, A., Avondo, V. Laburthe, M. 2006. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 147, 4977 4984.
68. Voisin, T., El Firar, A., Rouyer-Fessard, C., Gratio, V. Laburthe, M. 2008. A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism. FASEB J 22, 1993 2002.
69. Williams, R.H. Burdakov, D. 2008. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 10, e28.
70. Wright, K.M., Linhoff, M.W., Potts, P.R. Deshmukh, M. 2004. Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. J Cell Biol 167, 303 313.
71. Ziolkowska, A., Spinazzi, R., Albertin, G., Nowak, M., Malendowicz, L.K., Totorella, C. Nussdorfer, G.G. 2005. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor. J Steroid Biochem Mol Biol 96, 423 429.